Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma
Clinical trial NCT05909098 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05909098
- Sponsor
- Xiangyang No.1 People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2026-12-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.